Ask your AI about this

Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:

Connect your AI · Plans and the 7-day free trial (card required)

Buying and selling by quarter

Dollars bought and sold on the open market over the last two years.

$0$20.0M$40.0M$60.0MQ4 2024 · Bought: $0Q4 2024 · Sold: $5,200,459Q4 2024Q3 2025 · Bought: $0Q3 2025 · Sold: $11,884,661Q3 2025Q2 2026 · Bought: $0Q2 2026 · Sold: $54,295,119Q2 2026

Bought Sold

By trade date, using the shares and price reported for each trade. Stock grants, option exercises and shares withheld for tax are left out.

Roles

The companies where this person reports as an insider, and their position at each, most recent first.

Roles by company
MSFT
Microsoft Corporation
DirectorSep 11, 2026
AUR
Aurora Innovation, Inc.
DirectorMay 28, 2026
VOR
Vor Biopharma Inc.
10% ownerSep 18, 2025

Roles come from the filings themselves and can change over time.

Latest open-market trades

Purchases and sales at every company, most recent filing first.

Latest insider trades
How the stock has done since the trade date, measured against the S&P 500 over the same days. It describes the stock, not the trader's actual gain or loss.Filing
May 28, 2026AUR
Aurora Innovation, Inc.
Sale1.08M$7.27$7.9M-40.4%Form 4 ↗
May 28, 2026AUR
Aurora Innovation, Inc.
Sale60,118$7.27$437.1K-40.4%Form 4 ↗
May 28, 2026AUR
Aurora Innovation, Inc.
Sale60,118$7.27$437.1K-40.4%Form 4 ↗
May 18, 2026AUR
Aurora Innovation, Inc.
Sale17,382$7.51$130.5K-45.4%Form 4 ↗
May 18, 2026AUR
Aurora Innovation, Inc.
Sale312,882$7.51$2.3M-45.4%Form 4 ↗
May 18, 2026AUR
Aurora Innovation, Inc.
Sale17,382$7.51$130.5K-45.4%Form 4 ↗
May 15, 2026AUR
Aurora Innovation, Inc.
Sale274,925$7.81$2.1M-47.5%Form 4 ↗
May 15, 2026AUR
Aurora Innovation, Inc.
Sale4.95M$7.81$38.6M-47.5%Form 4 ↗
May 15, 2026AUR
Aurora Innovation, Inc.
Sale274,925$7.81$2.1M-47.5%Form 4 ↗
Sep 16, 2025VOR
Vor Biopharma Inc.
Sale447,278$1.54$688.8K-52.5%Form 4 ↗
Sep 15, 2025VOR
Vor Biopharma Inc.
Sale400,000$1.64$656.0K-53.5%Form 4 ↗
Sep 12, 2025VOR
Vor Biopharma Inc.
Sale300,000$1.75$525.0K-58.9%Form 4 ↗
Sep 11, 2025VOR
Vor Biopharma Inc.
Sale284,805$1.83$521.2K-61.2%Form 4 ↗
Sep 10, 2025VOR
Vor Biopharma Inc.
Sale350,000$1.82$637.0K-61.7%Form 4 ↗
Sep 9, 2025VOR
Vor Biopharma Inc.
Sale449,226$2.00$898.5K-67.7%Form 4 ↗
Sep 8, 2025VOR
Vor Biopharma Inc.
Sale464,421$1.99$924.2K-67.2%Form 4 ↗
Sep 5, 2025VOR
Vor Biopharma Inc.
Sale400,000$1.97$788.0K-67.0%Form 4 ↗
Sep 4, 2025VOR
Vor Biopharma Inc.
Sale453,016$1.93$874.3K-65.9%Form 4 ↗
Sep 3, 2025VOR
Vor Biopharma Inc.
Sale554,612$2.00$1.1M-68.6%Form 4 ↗
Aug 28, 2025VOR
Vor Biopharma Inc.
Sale806,351$2.01$1.6M-67.9%Form 4 ↗
Aug 27, 2025VOR
Vor Biopharma Inc.
Sale611,647$2.01$1.2M-68.1%Form 4 ↗
Aug 26, 2025VOR
Vor Biopharma Inc.
Sale284,190$2.08$591.1K-70.2%Form 4 ↗
Aug 25, 2025VOR
Vor Biopharma Inc.
Sale387,346$2.12$821.2K-70.3%Form 4 ↗
Dec 30, 2024VOR
Vor Biopharma Inc.
Buy38.97M——-46.6%Form 4 ↗
Nov 18, 2024AUR
Aurora Innovation, Inc.
Sale26,892$5.48$147.4K-59.8%Form 4 ↗
Nov 18, 2024AUR
Aurora Innovation, Inc.
Sale484,053$5.48$2.7M-59.8%Form 4 ↗
Nov 18, 2024AUR
Aurora Innovation, Inc.
Sale26,892$5.48$147.4K-59.8%Form 4 ↗
Nov 15, 2024AUR
Aurora Innovation, Inc.
Sale22,352$5.04$112.7K-44.4%Form 4 ↗
Nov 15, 2024AUR
Aurora Innovation, Inc.
Sale402,342$5.04$2.0M-44.4%Form 4 ↗
Nov 15, 2024AUR
Aurora Innovation, Inc.
Sale22,352$5.04$112.7K-44.4%Form 4 ↗
Nov 14, 2024AUR
Aurora Innovation, Inc.
Sale75,756$5.37$406.8K-48.9%Form 4 ↗
Nov 14, 2024AUR
Aurora Innovation, Inc.
Sale1.36M$5.37$7.3M-48.9%Form 4 ↗
Nov 14, 2024AUR
Aurora Innovation, Inc.
Sale75,756$5.37$406.8K-48.9%Form 4 ↗
Nov 13, 2024AUR
Aurora Innovation, Inc.
Sale1.06M$5.60$6.0M-46.7%Form 4 ↗
Nov 13, 2024AUR
Aurora Innovation, Inc.
Sale59,070$5.60$330.8K-46.7%Form 4 ↗
Nov 13, 2024AUR
Aurora Innovation, Inc.
Sale59,070$5.60$330.8K-46.7%Form 4 ↗
Nov 12, 2024AUR
Aurora Innovation, Inc.
Sale1.51M$5.37$8.1M-48.4%Form 4 ↗
Nov 12, 2024AUR
Aurora Innovation, Inc.
Sale84,029$5.37$451.2K-48.4%Form 4 ↗
Nov 12, 2024AUR
Aurora Innovation, Inc.
Sale84,029$5.37$451.2K-48.4%Form 4 ↗
Nov 11, 2024AUR
Aurora Innovation, Inc.
Sale42,840$5.49$235.2K-48.9%Form 4 ↗
Nov 11, 2024AUR
Aurora Innovation, Inc.
Sale771,117$5.49$4.2M-48.9%Form 4 ↗
Nov 11, 2024AUR
Aurora Innovation, Inc.
Sale42,840$5.49$235.2K-48.9%Form 4 ↗
Nov 8, 2024AUR
Aurora Innovation, Inc.
Sale41,486$5.54$229.8K-51.1%Form 4 ↗
Nov 8, 2024AUR
Aurora Innovation, Inc.
Sale41,486$5.54$229.8K-51.1%Form 4 ↗
Nov 8, 2024AUR
Aurora Innovation, Inc.
Sale746,741$5.54$4.1M-51.1%Form 4 ↗
Nov 7, 2024AUR
Aurora Innovation, Inc.
Sale30,000$5.53$165.9K-50.0%Form 4 ↗
Nov 7, 2024AUR
Aurora Innovation, Inc.
Sale540,000$5.53$3.0M-50.0%Form 4 ↗
Nov 7, 2024AUR
Aurora Innovation, Inc.
Sale30,000$5.53$165.9K-50.0%Form 4 ↗
Nov 6, 2024AUR
Aurora Innovation, Inc.
Sale175,001$5.58$976.5K-53.9%Form 4 ↗
Nov 6, 2024AUR
Aurora Innovation, Inc.
Sale175,000$5.58$976.5K-53.9%Form 4 ↗
Nov 6, 2024AUR
Aurora Innovation, Inc.
Sale3.15M$5.58$17.6M-53.9%Form 4 ↗
Nov 5, 2024AUR
Aurora Innovation, Inc.
Sale115,000$5.17$594.5K-49.5%Form 4 ↗
Nov 5, 2024AUR
Aurora Innovation, Inc.
Sale2.07M$5.17$10.7M-49.5%Form 4 ↗
Nov 5, 2024AUR
Aurora Innovation, Inc.
Sale115,000$5.17$594.5K-49.5%Form 4 ↗
Nov 4, 2024AUR
Aurora Innovation, Inc.
Sale1.25M$5.45$6.8M-56.5%Form 4 ↗
Nov 4, 2024AUR
Aurora Innovation, Inc.
Sale69,694$5.45$379.8K-56.5%Form 4 ↗
Nov 4, 2024AUR
Aurora Innovation, Inc.
Sale69,694$5.45$379.8K-56.5%Form 4 ↗

Each row links to its Form 4. Since trade compares the stock’s move from the close on the trade date (or the next trading day) to its latest close with the S&P 500 over the same days, adjusted for splits and excluding dividends. It describes the stock, not what the trader made: we don’t know their purchase price, position size or later sales. A dash means the trade isn’t matched to a listed stock, or there is no closing price after it yet.

When several people report on the same filing, we list it under the first one named, so trades by someone usually listed second may be missing here. Information, not investment advice: see the disclaimer.